Five people who are inspired by the bleeding disorders community are lacing up for an immense physical challenge: running the TCS New York City Marathon on November 2, 2025. They’ll be running across the Verrazano-Narrows Bridge, through the streets…
With the fall scholastic season now in full swing, we thought it would be a great time to share a few back-to-school resources to support students, families, and school personnel. This edition of the Resource Roundup features articles, educational…
While it is generally understood that the social determinants of health (SDOH) are significant factors contributing to an individual’s overall health, research specific to SDOH and its impact upon the bleeding disorders community has been rather…
Speakers: Aaron Blocker, Matt Delaney, Miriam Goldstein, Johanna Gray Description: With open enrollment just around the corner -- and with many changes coming out of Washington DC and state capitols --…
Speakers: Brian Branchford, MD; Ariel LoraineDescription: Explore the experience of factor X deficiency (FX), an ultra-rare bleeding disorder, from understanding mild to severe bleeding, joint complications, and…
Novo Nordisk has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for Mim8 (denecimig), an investigational bispecific antibody therapy. The antibody promotes coagulation by binding two key proteins (…
Speakers: Guy Young, MDDescription: Join Dr. Young, speaking on behalf of HEMA Biologics, for an informative conversation about a treatment option for hemophilia A or B with inhibitors. This session will share…